Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1983 • 52,849 citations

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

1978 • 1,668 citations

Fundamental Immunology

1990 • 607 citations

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

1986 • 561 citations

Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

1987 • 538 citations

Inhibition of Cellular Proliferation by Antisense Oligodeoxynucleotides to PCNA Cyclin

1988 • 425 citations

Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.

1987 • 361 citations

Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.

1981 • 338 citations

Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

1987 • 333 citations

Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

1987 • 211 citations

Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells

1988 • 125 citations

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells

1981 • 102 citations

Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors

1989 • 101 citations

‘Nonspecific’ MHC-unrestricted killer cells and their receptors

1987 • 98 citations

Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells.

1986 • 84 citations

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes

1987 • 54 citations

Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.

1988 • 47 citations

Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation.

1989 • 44 citations

Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.

1986 • 36 citations

The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels

1988 • 33 citations

Fluorescence anisotropy of cell membranes of doxorubicin-sensitive and -resistant rodent tumoral cells.

1986 • 30 citations

Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide.

1987 • 21 citations

Potentiation of adoptive immunotherapy by cis‐diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden

1988 • 21 citations

T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: Evidence with a single T cell clone

1990 • 19 citations

Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance

1989 • 16 citations

Differential lysis of melanoma clones by autologous recombinant interleukin 2‐activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx)

1988 • 12 citations

Reduced cytotoxicity of tetracyclines to a multi-drug resistant human cell line

1988 • 8 citations